Cargando…

A quinazoline derivative suppresses B cell hyper-activation and ameliorates the severity of systemic lupus erythematosus in mice

Background: Aberrant autoreactive B cell responses contribute to the pathogenesis of systemic lupus erythematosus (SLE). Currently, there is no safe and effective drug for intervention of SLE. Quinazoline derivative (N4-(4-phenoxyphenethyl)quinazoline-4,6-diamine, QNZ) is a NF-κB inhibitor and has p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Gan, Yang, Fan, Li, Juan, Chen, Shan, Kong, Yuhang, Mo, Chunfen, Leng, Xiao, Liu, Yang, Xu, Ying, Wang, Yantang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225574/ https://www.ncbi.nlm.nih.gov/pubmed/37256224 http://dx.doi.org/10.3389/fphar.2023.1159075

Ejemplares similares

Regulatory Dendritic Cells Induced by K313 Display Anti-Inflammatory Properties and Ameliorate Experimental Autoimmune Encephalitis in Mice
por: Zhou, Yan, et al.
Publicado: (2020)

Pseudolycorine chloride ameliorates Th17 cell-mediated central nervous system autoimmunity by restraining myeloid-derived suppressor cell expansion
por: Zhang, Gan, et al.
Publicado: (2022)

Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance
por: Zhou, Yan, et al.
Publicado: (2016)

The Microbiota in Systemic Lupus Erythematosus: An Update on the Potential Function of Probiotics
por: Guo, Xirui, et al.
Publicado: (2021)

Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment
por: Celhar, Teja, et al.
Publicado: (2014)

Clinical Experience of Sirolimus Regarding Efficacy and Safety in Systemic Lupus Erythematosus
por: Eriksson, Per, et al.
Publicado: (2019)

Magnoflorine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via Suppressing NF-κB and MAPK Activation
por: Guo, Shuai, et al.
Publicado: (2018)

The rapid inhibition of B-cell activation markers by belimumab was associated with disease control in systemic lupus erythematosus patients
por: Wang, Jing, et al.
Publicado: (2023)

Genetic Polymorphisms and the Clinical Response to Systemic Lupus Erythematosus Treatment Towards Personalized Medicine
por: Barliana, Melisa Intan, et al.
Publicado: (2022)

Perturbed autophagy intervenes systemic lupus erythematosus by active ingredients of traditional Chinese medicine
por: Tian, Rui, et al.
Publicado: (2023)

Tomatidine Suppresses the Destructive Behaviors of Fibroblast-Like Synoviocytes and Ameliorates Type II Collagen-Induced Arthritis in Rats
por: Yu, Xiaolu, et al.
Publicado: (2021)

Hepatoprotective potential of a novel quinazoline derivative in thioacetamide-induced liver toxicity
por: Salama, Suzy, et al.
Publicado: (2022)

P2X7 Receptor Expression in Patients With Serositis Related to Systemic Lupus Erythematosus
por: Furini, Federica, et al.
Publicado: (2019)

Medicinal Plant Extracts and Natural Compounds for the Treatment of Cutaneous Lupus Erythematosus: A Systematic Review
por: Lubov, Janet E., et al.
Publicado: (2022)

Association of lipid lowering drugs and the risk of systemic lupus erythematosus: a drug target Mendelian randomization
por: Wu, Tong, et al.
Publicado: (2023)

Ginsenoside F1 Ameliorates Endothelial Cell Inflammatory Injury and Prevents Atherosclerosis in Mice through A20-Mediated Suppression of NF-kB Signaling
por: Qin, Meng, et al.
Publicado: (2017)

Case report: NUDT15 polymorphism and severe azathioprine-induced myelosuppression in a young Chinese female with systematic lupus erythematosus: a case analysis and literature review
por: Gu, Juan, et al.
Publicado: (2023)

Saponins from Panax notoginseng ameliorate steroid resistance in lupus nephritis through regulating lymphocyte-derived exosomes in mice
por: Chen, Jia, et al.
Publicado: (2022)

Triptolide in the treatment of systemic lupus erythematosus - regulatory effects on miR-146a in B cell TLR7 signaling pathway in mice
por: Zhang, Yi, et al.
Publicado: (2022)

Traditional Chinese medicine use is associated with lower risk of pneumonia in patients with systemic lupus erythematosus: a population-based retrospective cohort study
por: Wang, Weijie, et al.
Publicado: (2023)

Upregulation of microRNA‐762 suppresses the expression of GIPC3 in systemic lupus erythematosus and neuropsychiatric systemic lupus erythematosus
por: Yang, Jijuan, et al.
Publicado: (2022)

A Novel Network Pharmacology Strategy to Decode Mechanism of Lang Chuang Wan in Treating Systemic Lupus Erythematosus
por: Gao, Yao, et al.
Publicado: (2020)

PK/PD Study of Mycophenolate Mofetil in Children With Systemic Lupus Erythematosus to Inform Model-Based Precision Dosing
por: Chen, Yewei, et al.
Publicado: (2020)

Efficacy and Safety of Qinghao Biejia Decoction in the Treatment of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
por: Li, Xiaobo, et al.
Publicado: (2021)

Efficacy and safety of total glucosides of paeony in the treatment of systemic lupus erythematosus: A systematic review and meta-analysis
por: Gong, Xiaohong, et al.
Publicado: (2022)

Specificity of anti-SSB as a diagnostic marker for the classification of systemic lupus erythematosus
por: RAO, LI, et al.
Publicado: (2013)

3D,2D-QSAR study and docking of novel quinazolines as potential target drugs for osteosarcoma
por: Lian, Zheng, et al.
Publicado: (2023)

Ginsenoside Rg1 Ameliorates Neuroinflammation via Suppression of Connexin43 Ubiquitination to Attenuate Depression
por: Wang, Huiqin, et al.
Publicado: (2021)

Administration of SB239063 Ameliorates Ovariectomy-Induced Bone Loss via Suppressing Osteoclastogenesis in Mice
por: Huang, Bao, et al.
Publicado: (2019)

Overexpression of FcγRIIB regulates downstream protein phosphorylation and suppresses B cell activation to ameliorate systemic lupus erythematosus
por: Sheng, Linlin, et al.
Publicado: (2020)

Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab
por: Regola, Francesca, et al.
Publicado: (2019)

Antimalarials may reduce cancer risk in patients with systemic lupus erythematosus: a systematic review and meta-analysis of prospective studies
por: Li, Xian-Bao, et al.
Publicado: (2021)

Total Glucosides of Paeonia lactiflora for Safely Reducing Disease Activity in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
por: Chen, Yifan, et al.
Publicado: (2022)

Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors
por: Boudou, Cédric, et al.
Publicado: (2022)

Scutellarin Ameliorates Renal Injury via Increasing CCN1 Expression and Suppressing NLRP3 Inflammasome Activation in Hyperuricemic Mice
por: Li, Guozheng, et al.
Publicado: (2020)

Beyond Systemic Lupus Erythematosus and Anti-Phospholipid Syndrome: The Relevance of Complement From Pathogenesis to Pregnancy Outcome in Other Systemic Rheumatologic Diseases
por: Cavalli, Silvia, et al.
Publicado: (2022)

Tripterygium glycosides for safely controlling disease activity in systemic lupus erythematosus: a systematic review with meta-analysis and trial sequential analysis
por: Chen, Yifan, et al.
Publicado: (2023)

Erratum: Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors
por: Frontiers Production Office,
Publicado: (2023)

Shema Oral Liquid Ameliorates the Severity of LPS-Induced COPD via Regulating DNMT1
por: Zhang, Fangbo, et al.
Publicado: (2022)

Inhibition of HDAC6 With CAY10603 Ameliorates Diabetic Kidney Disease by Suppressing NLRP3 Inflammasome
por: Hou, Qing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_faaj21aundanl7os27lapip8sf